Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
Saved in:
| Title: | Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors. |
|---|---|
| Authors: | Pan C; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA., Ng K; Clinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA., Voutsinas J; Clinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA., Barber B; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA., Rizvi ZH; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA.; Department of Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA., Marchiano E; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA., Ferrandino RM; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA., Futran N; Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA, USA., Laramore GE; Department of Radiation Oncology, University of Washington, Seattle, WA, USA., Liao JJ; Department of Radiation Oncology, University of Washington, Seattle, WA, USA., Parvathaneni U; Department of Radiation Oncology, University of Washington, Seattle, WA, USA., Panjwani N; Department of Radiation Oncology, University of Washington, Seattle, WA, USA., Martins RG; Division of Hematology, Oncology and Palliative Care, Department of Medicine, Virginia Commonwealth University, Richmond, VA, USA., Rodriguez CP; Division of Oncology, Department of Medicine, University of Washington, Seattle, WA, USA., Wu QV; Clinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA. qwu@fredhutch.org. |
| Source: | BMC cancer [BMC Cancer] 2024 Nov 15; Vol. 24 (1), pp. 1406. Date of Electronic Publication: 2024 Nov 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2407 |
|---|---|
| DOI: | 10.1186/s12885-024-13051-6 |
